These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4055040

  • 21. Staphylococcus aureus septicaemia treated with cefotaxime.
    Shah PM.
    Infection; 1985; 13 Suppl 1():S34-6. PubMed ID: 4055053
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cefmenoxime: clinical evaluation.
    Baker RL, Perkins RL.
    Am J Med; 1984 Dec 21; 77(6A):53-9. PubMed ID: 6097126
    [Abstract] [Full Text] [Related]

  • 24. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
    Höffken G, Pasold R, Pflüger KH, Finke J, Fauser AA, Szelenyi H, Wagner J.
    J Antimicrob Chemother; 1999 Sep 21; 44(3):367-76. PubMed ID: 10511404
    [Abstract] [Full Text] [Related]

  • 25. [Fundamental and clinical investigations of cefotaxime in neonates].
    Hashira S, Koike Y, Fujii R.
    Jpn J Antibiot; 1982 Jul 21; 35(7):1737-48. PubMed ID: 6294355
    [Abstract] [Full Text] [Related]

  • 26. [Ceftazidime versus cefotaxime in the therapy of severe infections in intensive care patients].
    Müller E, Heinkelein J.
    Infection; 1987 Jul 21; 15 Suppl 4():S173-8. PubMed ID: 3312030
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of cefotaxime for postoperative infection in surgery].
    Nakanishi Y, Kasai Y, Maeda A, Hasegawa N, Hasegawa M, Gotoh Y, Higa T, Takamura M, Yagi Y, Nakamura T.
    Jpn J Antibiot; 1984 Sep 21; 37(9):1729-50. PubMed ID: 6096587
    [Abstract] [Full Text] [Related]

  • 28. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
    Francke EL, Neu HC.
    Am J Med; 1981 Sep 21; 71(3):435-42. PubMed ID: 6269426
    [Abstract] [Full Text] [Related]

  • 29. Longitudinal surveillance on antibiogram of important Gram-positive pathogens in Southern China, 2001 to 2015.
    Xu Z, Xie J, Peters BM, Li B, Li L, Yu G, Shirtliff ME.
    Microb Pathog; 2017 Feb 21; 103():80-86. PubMed ID: 27894963
    [Abstract] [Full Text] [Related]

  • 30. Cefotaxime in the treatment of prophylaxis of surgical infections.
    Wittmann DH, Jones RN, Malledant J, Privitera G.
    J Chemother; 1997 May 21; 9 Suppl 2():19-33. PubMed ID: 9248973
    [Abstract] [Full Text] [Related]

  • 31. [Therapeutic effects of cefmenoxime in the treatment of various infections on infants and children].
    Kurashige T, Wakiguchi H, Kitamura I, Ozaki H, Nishibayashi Y, Hamawaki M.
    Jpn J Antibiot; 1982 Nov 21; 35(11):2579-88. PubMed ID: 6302339
    [Abstract] [Full Text] [Related]

  • 32. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N, van Laethem Y, Vanhoof R, George C, Rapin M, Butzler JP.
    Scand J Infect Dis; 1982 Nov 21; 14(1):57-60. PubMed ID: 6280269
    [Abstract] [Full Text] [Related]

  • 33. Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections.
    Diaz-Mitoma F, Harding GK, Louie TJ, Thomson M, James M, Ronald AR.
    Rev Infect Dis; 1985 Nov 21; 7 Suppl 3():S452-7. PubMed ID: 3901207
    [Abstract] [Full Text] [Related]

  • 34. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D, Argüello EA, Jasovich A, Villar O, Maglio F.
    Rev Infect Dis; 1985 Nov 21; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of cefotaxime in bacterial infections.
    Varghese M, Khan AJ, Kumar K, Schaeffer HA, Pierro M, Evans HE.
    Clin Pediatr (Phila); 1984 Apr 21; 23(4):220-2. PubMed ID: 6321080
    [Abstract] [Full Text] [Related]

  • 36. [Bacteriological and clinical studies of cefodizime in pediatrics].
    Akita H, Sato Y, Iwata S, Sunakawa K.
    Jpn J Antibiot; 1991 Apr 21; 44(4):398-411. PubMed ID: 1880919
    [Abstract] [Full Text] [Related]

  • 37. Cefotaxime in the treatment of meningitis.
    Cherubin CE, LeFrock J.
    Infection; 1985 Apr 21; 13 Suppl 1():S68-72. PubMed ID: 4055058
    [Abstract] [Full Text] [Related]

  • 38. Treatment of 160 cases of acute bacterial meningitis with cefotaxime.
    Lecour H, Seara A, Miranda AM, Cordeiro J, Sarmento J.
    J Antimicrob Chemother; 1984 Sep 21; 14 Suppl B():195-202. PubMed ID: 6094440
    [Abstract] [Full Text] [Related]

  • 39. A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover.
    Morris DL, Wilson SR, Pain J, Edwardson KF, Jones J, Strachan C, Slack R.
    J Antimicrob Chemother; 1990 Apr 21; 25(4):673-8. PubMed ID: 2190974
    [Abstract] [Full Text] [Related]

  • 40. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG, Lam A, Schweizer F, Thomson K, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Noreddin AM, Karlowsky JA.
    Am J Clin Dermatol; 2008 Apr 21; 9(4):245-54. PubMed ID: 18572975
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.